DIFFERENCES BETWEEN HEPATITIS HCV-MONOINFECTED AND HCV-HIV-COINFECTED PATIENTS TREATED WITH NEW DAA-BASED THERAPIES

被引：0

作者：

Montes, M. L. ^{[1
]}

Ahumada, A. ^{[2
]}

Aldamiz, T. ^{[3
]}

Olveira, A. ^{[4
]}

Bailon, L. ^{[1
]}

Garcia-Samaniego, J. ^{[4
]}

Berenguer, J. ^{[3
]}

Perez-Valderas, D. ^{[2
]}

Moreno, V. ^{[1
]}

Miralles, P. ^{[3
]}

Castillo, P. ^{[4
]}

Rincon, D. ^{[2
]}

Valencia, E. ^{[1
]}

Romero, M. ^{[4
]}

Carlos, J. de Quiros L. B. ^{[3
]}

Catalina, M. V. ^{[2
]}

Garcia, A. ^{[4
]}

Parras, F. ^{[3
]}

Matilla, A. ^{[2
]}

Abadia, M. ^{[4
]}

Rico, M. ^{[1
]}

Martin-Carbonero, L. ^{[1
]}

机构：

[1] Hosp Univ La Paz, IdiPaz, Unidad VIH, Med Interna Serv, Madrid, Spain

[2] Hosp Gen Univ Gregorio Maranon, Unidad Hepatol, Serv Digest, CIBERehd, Madrid, Spain

[3] Hosp Gen Univ Gregorio Maranon, Unidad VIH, Serv Enfermedades Infecciosas, Inst Invest Sanitaria HGM, Madrid, Spain

[4] Hosp Univ La Paz, Unidad Hepatol, Serv Digest, CIBERehd, Madrid, Spain

来源：

JOURNAL OF HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

10.1016/S0168-8278(16)01546-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-206

引用

页码：S793 / S793

页数：1

共 50 条

[21] Increase in 10-Year Framingham Cardiovascular Risk Following HCV Eradication with DAA-Based Therapy in HIV/HCV-Coinfected Patients
Aldamiz-Echevarria, Teresa
Diez, Cristina
Miralles, Pilar
Lopez, Juan C.
Parras, Francisco
Gijon, Paloma
Padilla, Belen
Montillai, Pedro
Sanchez-Somolinos, Mar
Bellon, Jose M.
Berenguer, Juan
HEPATOLOGY, 2016, 64 : 1009A - 1009A
[22] Effectiveness of 8 weeks of ledipasvir/sofosbuvir for hepatitis C in HCV-HIV-coinfected patients
Vega, Ana D.
Hynicka, Lauren M.
Claeys, Kimberly
Chua, Joel, V
Heil, Emily L.
ANTIVIRAL THERAPY, 2019, 24 (01) : 11 - 17
[23] HIV COINFECTION IMPAIRS RESPONSE TO DAA-BASED HCV THERAPY
Neukam, K.
Suarez-Santamaria, M.
Rivero-Juarez, A.
Romero-Palacios, A.
Ortega, E.
de los Santos-Gil, I.
Cucurull, J.
Vera-Mendez, F.
Pineda, J. A.
JOURNAL OF HEPATOLOGY, 2016, 64 : S219 - S219
[24] Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects
Butt, A. A.
Justice, A. C.
Skanderson, M.
Good, C.
Kwoh, C. K.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (04) : 585 - 591
[25] Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects
Zuccala, Paola
Latronico, Tiziana
Marocco, Raffaella
Savinelli, Stefano
Vita, Serena
Mengoni, Fabio
Tieghi, Tiziana
Borgo, Cosmo
Kertusha, Blerta
Carraro, Anna
D'Ettorre, Gabriella
Vullo, Vincenzo
Mastroianni, Claudio Maria
Liuzzi, Grazia Maria
Lichtner, Miriam
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
[26] Estimated Liver Fibrosis and its Impact on All-Cause Mortality of HCV-Monoinfected and HCV/HIV-Coinfected Drug Users
Sanvisens, A.
Fuster, D.
Serra, I.
Tor, J.
Tural, C.
Rey-Joly, C.
Muga, R.
CURRENT HIV RESEARCH, 2011, 9 (04) : 256 - 262
[27] REAL-LIFE EXPERIENCE OF DAA-BASED REGIMENS PLUS RIBAVIRIN IN CIRRHOTIC PATIENTS COINFECTED WITH HCV AND HIV-1
Messina, E.
Uberti-Foppa, C.
Merli, M.
Galli, L.
Barbanotti, D.
Poli, A.
Salpietro, S.
Morsica, G.
Bagaglio, S.
Andolina, A.
Castagna, A.
Lazzarin, A.
Hasson, H.
JOURNAL OF HEPATOLOGY, 2016, 64 : S792 - S793
[28] Analysis of hepatitis C virus (HCV) RNA load in platelets of HCV-monoinfected patients receiving antiviral therapy
do Espirito-Santo, Marcia Paschoal
Brandao-Mello, Carlos Eduardo
Marques, Vanessa Alves
Lampe, Elisabeth
De Almeida, Adilson Jose
ANNALS OF HEPATOLOGY, 2013, 12 (03) : 373 - 379
[29] Should HIV/HCV coinfected patients with severe hepatitis be treated for hepatitis C
Rockstroh, JK
PRESSE MEDICALE, 2005, 34 (20): : 1585 - 1588
[30] Treatment of HCV with the New, Direct-Acting Antiviral Medications in HCV-Monoinfected and HIV-HCV-Coinfected Individuals from an Inner-City, Predominantly Minority Patient Population
Parvin, Russell
Haeri, Nami Safai
Nigar, Sofia
Ona, Mel A.
Reddy, Madhavi
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S374 - S375

← 1 2 3 4 5 →